Preventive blood thinners for ICU patients with kidney problems
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests giving a blood-thinning medication (heparin) to critically ill patients with serious kidney problems to see if it safely prevents blood clots. It may help reduce the risk of clots without raising bleeding risk in this vulnerable group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severely reduced kidney function, either from a low filtering rate or acute kidney failure.
- You are expected to stay in the intensive care unit for at least 2 days.
- You are not on long-term dialysis.
- You are not currently bleeding or have not had a recent major bleed during this hospital stay.
- You are not already taking full-dose blood thinners (anticoagulants) for a clot or heart condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a common blood thinner (enoxaparin) is processed in the body of ICU patients with kidney failure, including those on dialysis. The goal is to make sure the dose is safe and effective for preventing blood clots in this fragile group.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This trial tests whether the blood thinner rivaroxaban can prevent dangerous blood clots in people with a kidney condition called membranous nephropathy who have low albumin levels and are at high risk for clots.
This trial tests three experimental antibodies given to people with end-stage kidney disease who are on hemodialysis. It aims to see if these drugs are safe and how they affect blood clotting in this group.
This study compares two ways to prevent blood clots during kidney dialysis in people with sepsis-related kidney failure. The goal is to see which method is safer and works better to keep the dialysis filter working properly.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
Hear when a new Prophylactic Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.